<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2009-13-2-35-41</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1159</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>ОСОБЕННОСТИ  ПОРАЖЕНИЯ  ПОЧЕК  ПРИ  ДИФФУЗНЫХ  ЗАБОЛЕВАНИЯХ СОЕДИНИТЕЛЬНОЙ  ТКАНИ  И  СИСТЕМНЫХ  ВАСКУЛИТАХ  (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>THE SPECIALTIES OF THE  RENAL DAMAGE  IN  CONNECTIVE TISSUE  DISEASES AND SYSTEMIC VASCULITIS  (literature review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Долгих</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dolgih</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра терапии №1 им. Э.Э. Эйхвальда</p><p>191015, Санкт-Петербург, ул. Кирочная, 41, тел. (812) 272-26-42</p></bio><email xlink:type="simple">cord98@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьева</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorobieva</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра терапии №1 им. Э.Э. Эйхвальда</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мазуров</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Mazurov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра терапии №1 им. Э.Э. Эйхвальда</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Санкт-Петербургская медицинская академия последипломного образова­ния</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>10</day><month>02</month><year>2009</year></pub-date><volume>13</volume><issue>2</issue><fpage>35</fpage><lpage>41</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Долгих С.В., Воробьева О.А., Мазуров В.И., 2009</copyright-statement><copyright-year>2009</copyright-year><copyright-holder xml:lang="ru">Долгих С.В., Воробьева О.А., Мазуров В.И.</copyright-holder><copyright-holder xml:lang="en">Dolgih S.V., Vorobieva O.A., Mazurov V.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1159">https://journal.nephrolog.ru/jour/article/view/1159</self-uri><abstract><p>Обзор содержит сведения о характере поражения почек у больных диффузными заболеваниями соединительной ткани. Акцентируется внимание на таких нозологических формах как: ревматоидный артрит, системная красная волчанка, системная склеродермия, системные васкулиты. Обсуждаются вопросы диагностики, лечения и прогнозирования.</p></abstract><trans-abstract xml:lang="en"><p>The review consists of data on the specialties of the renal damage in patients with connective tissue diseases. The attention is given to such nosologic forms as rheumatoid arthritis, systemic lupus erythematosus, scleroderma, systemic vasculitis. The questions of diagnostics, treatment and prognosis were discussed.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>поражение почек</kwd><kwd>гломерулонефрит</kwd><kwd>диффузные заболевания соединительной ткани</kwd><kwd>ревматоидный  артрит</kwd><kwd>системная красная волчанка</kwd><kwd>системные васкулиты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>renal damage</kwd><kwd>glomerolonephritis</kwd><kwd>connective tissue diseases</kwd><kwd>rheumatoid arthritis</kwd><kwd>systemic lupus erythematosus</kwd><kwd>systemic vasculitis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">American College of Rheumatology Ad Hoc Committee on Clinical Guidelines: Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 2002; 46(2): 328-336</mixed-citation><mixed-citation xml:lang="en">American College of Rheumatology Ad Hoc Committee on Clinical Guidelines: Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 2002; 46(2): 328-336</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplan MJ, McCune WJ. New evidence for vascular disease in patients with early rheumatoid arthritis. Lancet 2003; 361(9363): 1068-1069</mixed-citation><mixed-citation xml:lang="en">Kaplan MJ, McCune WJ. New evidence for vascular disease in patients with early rheumatoid arthritis. Lancet 2003; 361(9363): 1068-1069</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Мазуров ВИ, Беляева ИБ. Дерматомиозит. В: Мазуров ВИ, ред. Клиническая ревматология. Фолиант, СПб., 2005; 278-301</mixed-citation><mixed-citation xml:lang="en">Мазуров ВИ, Беляева ИБ. Дерматомиозит. В: Мазуров ВИ, ред. Клиническая ревматология. Фолиант, СПб., 2005; 278-301</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen AH, Nast CC. Kidney. Non-neoplastic conditions. Damjanov I, Linder J (eds). Anderson’s Pathology, 10th ed. – St. Louis: Mosby, 1996; 2073-2137</mixed-citation><mixed-citation xml:lang="en">Cohen AH, Nast CC. Kidney. Non-neoplastic conditions. Damjanov I, Linder J (eds). Anderson’s Pathology, 10th ed. – St. Louis: Mosby, 1996; 2073-2137</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">D’Agati VD, Jennette JC, Silva FG. Atlas of non-neoplastic kidney pathology. Washington: AFIP, 2005; 721</mixed-citation><mixed-citation xml:lang="en">D’Agati VD, Jennette JC, Silva FG. Atlas of non-neoplastic kidney pathology. Washington: AFIP, 2005; 721</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Weening JJ, D’Agati VD, Schwartz MM. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15(2): 241-250</mixed-citation><mixed-citation xml:lang="en">Weening JJ, D’Agati VD, Schwartz MM. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15(2): 241-250</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Edworthy SM. Clinical Manifestations of Systemic Lupus Erythematosus. In: Harris ED, et al, Eds. Kelley’s Textbook of Rheumatology, 7th Edition. Saunders, 2005; 1201-1224</mixed-citation><mixed-citation xml:lang="en">Edworthy SM. Clinical Manifestations of Systemic Lupus Erythematosus. In: Harris ED, et al, Eds. Kelley’s Textbook of Rheumatology, 7th Edition. Saunders, 2005; 1201-1224</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Fogo AB, Bruijn JA, Cohen AH et al. Fundamentals of renal pathology. New York:Springer Science + Business Media, LLC, 2006; 221</mixed-citation><mixed-citation xml:lang="en">Fogo AB, Bruijn JA, Cohen AH et al. Fundamentals of renal pathology. New York:Springer Science + Business Media, LLC, 2006; 221</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gordon C. Long-term complications of systemic lupus erythematosus. Rheumatology (Oxford) 2002; 41(10): 1095-1100</mixed-citation><mixed-citation xml:lang="en">Gordon C. Long-term complications of systemic lupus erythematosus. Rheumatology (Oxford) 2002; 41(10): 1095-1100</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Medsger TA. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am 2003; 29(2): 255-273</mixed-citation><mixed-citation xml:lang="en">Medsger TA. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am 2003; 29(2): 255-273</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Steen VD. Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol 2005; 32(4): 649-655</mixed-citation><mixed-citation xml:lang="en">Steen VD. Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol 2005; 32(4): 649-655</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов ЕЛ, Шилкина НП, Баранов АА. Лечение больных с системными васкулитами (обзор). Тер арх 1998; (11): 53-58</mixed-citation><mixed-citation xml:lang="en">Насонов ЕЛ, Шилкина НП, Баранов АА. Лечение больных с системными васкулитами (обзор). Тер арх 1998; (11): 53-58</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Шилкина НП. Диагностика системных васкулитов. Врач 2000; (5): 16-17</mixed-citation><mixed-citation xml:lang="en">Шилкина НП. Диагностика системных васкулитов. Врач 2000; (5): 16-17</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Jennette JC, Falk RJ. The pathology of vasculitis involving the kidney. Am J Kidney Dis 1994; 24(1): 130-141</mixed-citation><mixed-citation xml:lang="en">Jennette JC, Falk RJ. The pathology of vasculitis involving the kidney. Am J Kidney Dis 1994; 24(1): 130-141</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Jennette JC, Olson JL, Schwartz MM et al. Heptinstall’s pathology of the kidney, 6 th ed. – Philadelphia: Lippincott Williams &amp; Wilkins, 2007; 1580</mixed-citation><mixed-citation xml:lang="en">Jennette JC, Olson JL, Schwartz MM et al. Heptinstall’s pathology of the kidney, 6 th ed. – Philadelphia: Lippincott Williams &amp; Wilkins, 2007; 1580</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Langford CA. Treatment of ANCA-associated vasculitis. N Engl J Med 2003; 349(1): 3-4</mixed-citation><mixed-citation xml:lang="en">Langford CA. Treatment of ANCA-associated vasculitis. N Engl J Med 2003; 349(1): 3-4</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Valajtis J. Renal glomerular disease. Atlas of electron microscopy with histopathological bases and immunofluorescence findings. Chicago: ASCP, 2002; 318</mixed-citation><mixed-citation xml:lang="en">Valajtis J. Renal glomerular disease. Atlas of electron microscopy with histopathological bases and immunofluorescence findings. Chicago: ASCP, 2002; 318</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Алексеев ВГ. К вопросу о клинико-морфологической диагностике гранулематоза Вегенера. Военно-медицинский журнал 1995; (12): 47-48</mixed-citation><mixed-citation xml:lang="en">Алексеев ВГ. К вопросу о клинико-морфологической диагностике гранулематоза Вегенера. Военно-медицинский журнал 1995; (12): 47-48</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Комаров ВТ, Хичина НС, Никишина АЮ и др. Клинические варианты гранулематоза Вегенера. Клин медицина 2001; (2): 66-68</mixed-citation><mixed-citation xml:lang="en">Комаров ВТ, Хичина НС, Никишина АЮ и др. Клинические варианты гранулематоза Вегенера. Клин медицина 2001; (2): 66-68</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Woywodt A. Haubitz M, Haller H. Wegener’s granulomatosis. Lancet 2006; 367(9519): 1362-1366</mixed-citation><mixed-citation xml:lang="en">Woywodt A. Haubitz M, Haller H. Wegener’s granulomatosis. Lancet 2006; 367(9519): 1362-1366</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hellmich B. Update on the pathogenesis of Churg-Strauss syndrome. Clin Exp Rheumatol 2003; 21(6) [Suppl 32]: 69-77</mixed-citation><mixed-citation xml:lang="en">Hellmich B. Update on the pathogenesis of Churg-Strauss syndrome. Clin Exp Rheumatol 2003; 21(6) [Suppl 32]: 69-77</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Todd DC, Cockcroft DW. Prolonged survival in Churg-Strauss syndrome. Ann Allergy Asthma Immunol 2004; 92(1): 92-93</mixed-citation><mixed-citation xml:lang="en">Todd DC, Cockcroft DW. Prolonged survival in Churg-Strauss syndrome. Ann Allergy Asthma Immunol 2004; 92(1): 92-93</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Snow MH, Radio S, Mikuls TR. Disseminated giant cell arthritis with inflammatory arthritis and C-ANCA. J Clin Rheumatol 2005; 11(4): 216-218</mixed-citation><mixed-citation xml:lang="en">Snow MH, Radio S, Mikuls TR. Disseminated giant cell arthritis with inflammatory arthritis and C-ANCA. J Clin Rheumatol 2005; 11(4): 216-218</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Varnholt H. Giant cell arteritis. CMAJ 2005; 173(12): 1490-1500</mixed-citation><mixed-citation xml:lang="en">Varnholt H. Giant cell arteritis. CMAJ 2005; 173(12): 1490-1500</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
